Among the various signal transduction pathways implicated in proatherogenic inflammation, the Toll-like receptor 4 (TLR4)/nuclear factor kappa B (NF-κB) pathway has recently aroused more attention due to its important roles in atherosclerosis [19–21]. The gene discussed is NFKB1; the disease is atherosclerosis.